Nonclinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,540,827
Award facts
- Contract value 51% obligated
-
- $4,540,826.86 Current, with exercised options
- $8,950,920.86 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,708 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $107,641 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $231,446 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $152,587 | |
| Original award | $4,057,861 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on April 1, 2020, with a ceiling value of $8.95 million for nonclinical services supporting the development of interventional agents for infectious diseases.
The order is issued under the Nonclinical Services for Development of Interventional Agents parent IDIQ. Work is performed in Menlo Park, CA, with an ultimate completion date of March 31, 2021. The contract is priced on a cost-plus-fixed-fee basis with no small business set-aside.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $4,540,827 on 75N93020F00003. Its potential value, with all options, is $8,950,921.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award